EC Number |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
---|
3.1.1.4 | -999 |
- |
- |
649793, 677479, 678486, 679119 |
3.1.1.4 | -999 |
- |
BthTX-I has no enzymatic activity |
650425 |
3.1.1.4 | -999 |
- |
crude enzyme has a specific activity of 0.00012 units/mg, after 7fold purification the enzyme has a specific activity of 0.00084 units/mg, at pH 8.0 and 37°C, one unit of activity is defined as the amount of protein which produces a decrease in 0.01 absorbance in 10 min at 740 nm |
716965 |
3.1.1.4 | -999 |
- |
fluorimetric assay for the determination of total phospholipase A2 activity in biological samples introducing the innovation of immobilized substrates on crosslinked polymeric membranes. The immobilized 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine, a fluorescent analogue of phosphatidylcholine, exhibits high stability for 3 months at 4°C and is not desorbed in the aqueous reaction mixture during analysis |
751440 |
3.1.1.4 | -999 |
- |
kinetic investigation of hydrophobic/hydrophilic effect in various W7O microemulsions, using isooctane as main solvents and alcohols from 1-butanol to 1-octanol as co-solvent, giving yields of more than 90%. Water-content in the microemulsion phase dominantly governed the initial reaction rate |
663908 |
3.1.1.4 | -999 |
- |
RVV-7 cytotoxic activity versus B16F10 melanoma cells, overview |
681057 |
3.1.1.4 | -999 |
- |
sensitive activity assay using radioiodinatable long-chain phosphatidylcholine, detection limit is 0.25 ng enzyme or 0.05 ng substrate |
663618 |
3.1.1.4 | -999 |
- |
sPLA2-X antiviral effect, overview |
681681 |
3.1.1.4 | -999 |
- |
substrate application in micelles |
679198 |
3.1.1.4 | -999 |
- |
synthesis of fluorogenic substrate analogues for rapid determination of head group modification on cell signaling |
663459 |